Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Kelly

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Urology|March 24, 1998
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretionJ D Wolchok, H W Herr, W K Kelly
Urology|January 1, 1996
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancerH I Scher, Z F Zhang, D Nanus, et al.
American Journal of Perinatology|May 1, 1992
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodiesH J Landy, C Kessler, W K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancerW K Kelly, T Curley, C Leibretz, et al.
Urology|May 1, 1996
Acid phosphatase: defining a role in androgen-independent prostate cancerG Steineck, W K Kelly, M Mazumdar, et al.
Nature Reviews. Cancer|March 21, 2002
Histone deacetylases and cancer: causes and therapiesP Marks, R A Rifkind, V M Richon, et al.
Urology|August 1, 1994
Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterinP K Schultz, W K Kelly, C Begg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Radiology|September 2, 1998
Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen levelL H Schwartz, L R LaTrenta, E Bonaccio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Urology|March 24, 1998
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretionJ D Wolchok, H W Herr, W K Kelly
Urology|January 1, 1996
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancerH I Scher, Z F Zhang, D Nanus, et al.
American Journal of Perinatology|May 1, 1992
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodiesH J Landy, C Kessler, W K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancerW K Kelly, T Curley, C Leibretz, et al.
Urology|May 1, 1996
Acid phosphatase: defining a role in androgen-independent prostate cancerG Steineck, W K Kelly, M Mazumdar, et al.
Nature Reviews. Cancer|March 21, 2002
Histone deacetylases and cancer: causes and therapiesP Marks, R A Rifkind, V M Richon, et al.
Urology|August 1, 1994
Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterinP K Schultz, W K Kelly, C Begg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Radiology|September 2, 1998
Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen levelL H Schwartz, L R LaTrenta, E Bonaccio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Pageof 4